These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28960674)

  • 1. Requisite role of vasohibin-2 in spontaneous gastric cancer formation and accumulation of cancer-associated fibroblasts.
    Suzuki Y; Kitahara S; Suematsu T; Oshima M; Sato Y
    Cancer Sci; 2017 Dec; 108(12):2342-2351. PubMed ID: 28960674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer.
    Guo X; Oshima H; Kitmura T; Taketo MM; Oshima M
    J Biol Chem; 2008 Jul; 283(28):19864-71. PubMed ID: 18495668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.
    Suenaga K; Kitahara S; Suzuki Y; Kobayashi M; Horie S; Sugawara J; Yaegashi N; Sato Y
    PLoS One; 2014; 9(9):e104728. PubMed ID: 25184477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasohibin-2 Aggravates Development of Ascending Aortic Aneurysms but not Abdominal Aortic Aneurysms nor Atherosclerosis in ApoE-Deficient Mice.
    Otaka N; Uchida HA; Okuyama M; Hada Y; Onishi Y; Kakio Y; Takeuchi H; Umebayashi R; Tanabe K; Subramanian V; Daugherty A; Sato Y; Wada J
    Am J Hypertens; 2021 May; 34(5):467-475. PubMed ID: 33180898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.
    Kitahara S; Suzuki Y; Morishima M; Yoshii A; Kikuta S; Shimizu K; Morikawa S; Sato Y; Ezaki T
    Mol Cancer; 2014 May; 13():99. PubMed ID: 24885408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
    Yamamoto M; Ozawa S; Ninomiya Y; Koyanagi K; Oguma J; Kazuno A; Hara H; Yatabe K; Kajiwara H; Nakamura N; Sato Y
    Esophagus; 2020 Jul; 17(3):289-297. PubMed ID: 31980976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
    Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
    Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
    Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
    Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.
    Tu M; Lu C; Lv N; Wei J; Lu Z; Xi C; Chen J; Guo F; Jiang K; Li Q; Wu J; Song G; Wang S; Gao W; Miao Y
    Cancer Lett; 2016 Dec; 383(2):272-281. PubMed ID: 27702660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Role of Vasohibin in Gastroenterological Cancers: A Meta-Analysis.
    Yamamoto M; Ozawa S; Koyanagi K; Ninomiya Y; Hara H; Kazuno A; Yatabe K; Higuchi T; Nakamura K; Nabeshima K; Sato Y
    Tohoku J Exp Med; 2022 Apr; 256(4):291-301. PubMed ID: 35296570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
    Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
    Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
    Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
    Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of vasohibin-2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer.
    Koyanagi T; Saga Y; Takahashi Y; Tamura K; Yoshiba T; Takahashi S; Taneichi A; Takei Y; Urabe M; Mizukami H; Fujiwara H
    Cancer Med; 2021 Apr; 10(8):2732-2739. PubMed ID: 33710778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
    Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
    Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
    Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
    Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
    Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
    Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.